AAAAAA
Results:
1-7
|
Results: 7
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Rogers, MK
Kenny, GM
Jarisch, J
Citation: Gp. Murphy et al., Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patients, PROSTATE, 43(1), 2000, pp. 59-62
Authors:
Murphy, GP
Elgamal, AAA
Troychak, MJ
Kenny, GM
Citation: Gp. Murphy et al., Follow-up ProstaScint (R) scans verify detection of occult soft-tissue recurrence after failure of primary prostate cancer therapy, PROSTATE, 42(4), 2000, pp. 315-317
Authors:
Murphy, GP
Su, S
Jarisch, J
Kenny, GM
Citation: Gp. Murphy et al., Serum levels of PSMA, PROSTATE, 42(4), 2000, pp. 318-319
Authors:
Tjoa, BA
Simmons, SJ
Elgamal, A
Rogers, M
Ragde, H
Kenny, GM
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Ba. Tjoa et al., Follow-up evaluation of a phase II prostate cancer vaccine trial, PROSTATE, 40(2), 1999, pp. 125-129
Authors:
Simmons, SJ
Tjoa, BA
Rogers, M
Elgamal, A
Kenny, GM
Ragde, H
Troychak, MJ
Boynton, AL
Murphy, GP
Citation: Sj. Simmons et al., GM-CSF as a systemic adjuvant in a phase II prostate cancer vaccine trial, PROSTATE, 39(4), 1999, pp. 291-297
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment, PROSTATE, 39(1), 1999, pp. 54-59
Authors:
Murphy, GP
Tjoa, BA
Simmons, SJ
Jarisch, J
Bowes, VA
Ragde, H
Rogers, M
Elgamal, A
Kenny, GM
Cobb, OE
Ireton, RC
Troychak, MJ
Salgaller, ML
Boynton, AL
Citation: Gp. Murphy et al., Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease, PROSTATE, 38(1), 1999, pp. 73-78
Risultati:
1-7
|